Alexis De Sieno Cardlytics, Inc. (CDLX) insider trading activity

Alexis De Sieno is Chief Financial Officer of Cardlytics, Inc.. Currently has a direct ownership of 195,417 shares of CDLX, which is worth approximately $381,063. The most recent transaction as insider was on Oct 02, 2025, when has been sold 8,493 shares (Common Stock) at a price of $2.27 per share, resulting in proceeds of $19,279. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 195K

13.71% 3M change

99.71% 12M change

Total Value Held $381,063

Alexis DeSieno Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 02 2025	SELL Open market or private sale	$19,279 $2.27 p/Share	8,493 Reduced 4.17%	195,417 Common Stock
Oct 01 2025	BUY Exercise of conversion of derivative security	-	14,350 Added 6.57%	203,910 Common Stock
Aug 15 2025	SELL Open market or private sale	$31,778 $1.22 p/Share	26,048 Reduced 12.08%	189,560 Common Stock
Aug 14 2025	BUY Exercise of conversion of derivative security	-	43,750 Added 16.87%	215,608 Common Stock
Jul 02 2025	SELL Open market or private sale	$13,036 $1.78 p/Share	7,324 Reduced 4.09%	171,858 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	-	14,349 Added 7.41%	179,182 Common Stock
May 15 2025	SELL Open market or private sale	$50,860 $1.94 p/Share	26,217 Reduced 13.72%	164,833 Common Stock
May 14 2025	BUY Exercise of conversion of derivative security	-	43,750 Added 18.63%	191,050 Common Stock
Apr 02 2025	SELL Open market or private sale	$14,476 $1.81 p/Share	7,998 Reduced 5.15%	147,300 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	14,350 Added 8.46%	155,298 Common Stock
Feb 18 2025	SELL Open market or private sale	$84,245 $3.4 p/Share	24,778 Reduced 14.95%	140,948 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	43,750 Added 20.89%	165,726 Common Stock
Jan 03 2025	SELL Open market or private sale	$32,494 $3.67 p/Share	8,854 Reduced 6.77%	121,976 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	14,349 Added 9.88%	130,830 Common Stock
Nov 15 2024	SELL Open market or private sale	$86,154 $3.43 p/Share	25,118 Reduced 17.74%	116,481 Common Stock
Nov 14 2024	BUY Exercise of conversion of derivative security	-	43,750 Added 23.6%	141,599 Common Stock
Oct 02 2024	SELL Open market or private sale	$23,059 $3.08 p/Share	7,487 Reduced 7.11%	97,849 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	-	14,350 Added 11.99%	105,336 Common Stock
Aug 15 2024	SELL Open market or private sale	$337,283 $3.71 p/Share	90,912 Reduced 49.98%	90,986 Common Stock
Aug 14 2024	BUY Exercise of conversion of derivative security	-	175,000 Added 49.03%	181,898 Common Stock
Jul 02 2024	SELL Open market or private sale	$59,235 $7.95 p/Share	7,451 Reduced 51.93%	6,898 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	14,349 Added 50.0%	14,349 Common Stock

Alexis De Sieno

Chief Financial Officer

Atlanta, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDLX shares.

Notify only if

Value

Insider Trading

Get notified when an Cardlytics, Inc. insider buys or sells CDLX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cardlytics, Inc.

Track Activities on CDLX

Account